Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» lurbinectedin
lurbinectedin
Jazz's $1B SCLC drug fails combo trial, quashing hopes of quick full approval
Endpoints
Thu, 12/3/20 - 10:52 am
Jazz Pharmaceuticals
lurbinectedin
small cell lung cancer
clinical trials
Jazz Pharma’s $1B bet pays off with accelerated lung cancer approval
Endpoints
Tue, 06/16/20 - 10:37 am
Jazz Pharma
PharmaMar
FDA
Zepzelca
lurbinectedin
small cell lung cancer
Jazz targets US launch of SCLC drug after FDA grants fast review
Pharmaforum
Mon, 02/17/20 - 10:21 am
PharmaMar
Jazz Pharmaceuticals
FDA
small cell lung cancer
lurbinectedin
priority review
Jazz rolls the dice on a billion-dollar gamble on a new drug for SCLC — shooting for a 2020 launch
Endpoints
Thu, 12/19/19 - 12:53 pm
Jazz Pharma
lurbinectedin
SCLC
PharmaMar
PharmaMar files for FDA approval of small cell lung cancer drug
Fierce Biotech
Tue, 12/17/19 - 10:37 am
PharmaMar
FDA
lurbinectedin
small cell lung cancer
After ovarian cancer flop, PharmaMar's lurbinectedin makes the cut in small cell lung cancer
Endpoints
Mon, 03/25/19 - 10:19 am
PharmaMar
ovarian cancer
lurbinectedin
relapsed small cell lung cancer
small cell lung cancer